Faculty

Institution

Unit

Venue

Rafael Santana-Davila, MD

Medical College of Wisconsin

Affiliations

Medical College of Wisconsin, Research

NoneRafael Santana-davila, Md is currently serving as a Medical College Of Wisconsin, Research faculty at Medical College of Wisconsin.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Rafael Santana-Davila, MD

Medical College of Wisconsin

You can click a keyword to filter the displayed items

oncology radiation oncology cancer treatment cancer research cancer care medicine pharmacology cancer immunotherapy thoracic oncology lung cancer cancer management clinical research medicinal research hematology cancer biology pharmacotherapy anti-cancer agents clinical trials health sciences tumor targeting medical mycology leukemia respiratory medicine surgical oncology cellular therapy tumor biology molecular cancer cancer genetics clinical radiation oncology cancer imaging drug targeting hematological malignancies radiation therapy drug trials oral cancer gastroesophageal junction phase ii trial thoracic surgery experimental medicine esophageal cancer cancer detection medical genetics cancer genomics genitourinary cancers benchmark studies clinical mycology antitumor activity molecular diagnostics enzyme inhibition cancer prevention cancer screening chromosome biology gastrointestinal oncology colorectal cancer bronchial neoplasm cytogenetics treatment-naive advanced gastric advanced gastric interim safety clinical activity elderly patients genetic aberrations research policy pulmonary blastoma multiple pulmonary nodule treatment and prevention cancer education pharmaceutical sciences novel therapies clinical practice guidelines plasma cell leukemia recurrent igh translocations urothelial carcinomas gastro-oesophageal cancer chromosome abnormalities prognostic factors health policy clinical effectiveness health services research public health

Notable Scholarly Works

Notable Federal Grants

Collaborators

Dual Pd ‐1 and Ctla4 Immune Checkpoint Blockade and Hypofractionated Radiation in Patients With Advanced Salivary Gland Cancers. Head & Neck (2025)

clinical radiation oncologyradiation therapyradiation oncologyoral pathologyhypofractionated radiationcancer immunotherapyradiologyoral cancertumor microenvironmentcancer cellscancer letterimmune checkpoint inhibitorsoncology

Napsin A-Specific T-Cell Clonotypes Are Associated With Improved Clinical Outcomes in Patients Receiving Checkpoint Immunotherapy for Metastatic Non-Small Cell Lung Cancer. Journal for ImmunoTherapy of Cancer (2025)

oncogenesradiation oncologycancer immunotherapyimmunologyimmunotherapylung cancercellular therapycancer immunosurveillancethoracic oncologycancer cellsimproved clinical outcomesimmune checkpoint inhibitorscheckpoint immunotherapy

A Multicenter Open-Label Randomized Phase II Study of Osimertinib With and Without Ramucirumab in Tyrosine Kinase Inhibitor–NaïVe Egfr -Mutant Metastatic Non–Small Cell Lung Cancer (Ramose Trial). Journal of Clinical Oncology (2024)

Xiuning LeJyoti D. PatelElaine ShumChristina BaikRachel E. SanbornCatherine A. ShuChul KimMary Jo FidlerRichard HallYasir Y. ElaminJanet TuGeorge BlumenscheinJianjun ZhangDon GibbonsCarl GayNisha A. MohindraYoung ChaeYanis BoumberJoshua SabariRafael Santana-DavilaShane RogosinBenjamin HerzbergBen CreelanBruna PelliniTawee TanvetyanonSimon HeekeMike HernandezJhanelle E. GrayAndreas SaltosJohn V. Heymach

pathologycancer discoverypharmacologythoracic oncologyprimary investigationdrug trialslung cancercancer researchpharmacotherapyoncogenesmedicinal researchfield trialsystems biologymetastasistumor targetingclinical researchramose trialtumor heterogeneityoncology

A Phase 1 Study Investigating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Antitumor Activity of Second Mitochondrial-Derived Activator of Caspases Mimetic Bgb-24714 as Monotherapy and in Combination With Chemotherapy in Patients With Advanced or Metastatic Solid Tumors. Sci Adv (2024)

oncogenesmetastasisradiation oncologyphase 1anti-cancer agentsmetronomic chemotherapymedicinal researchmolecular cancerpharmacologytherapeutic targetscaspases mimetic bgb-24714preliminary antitumor activitycancer treatmentoncology

Association of Napsin A-Specific T Cell Clonotypes With Durable Clinical Benefit to Immunotherapy in Patients With Metastatic Nsclc.. Journal of Clinical Oncology (2024)

Natalie J. MillerChristina S BaikJoel W. NealA. McGarry HoughtonViswam S. NairRafael Santana-DavilaSylvia LeeKeith D. EatonRenato G. MartinsHeather A. WakeleeSukhmani Kaur PaddaShin-Heng ChiouDiane Tseng

pathologyimmunologyadaptive immune systemclinical immunologycancer immunotherapyimmunotherapycancer researchmetastatic nsclchealth sciencesmedical mycologydurable clinical benefitmolecular cancercellular therapyclinical evidencecancer careclinical mycologyhematological malignanciesclinical researchleukemiaoncology

Early Fdg Pet Imaging and Circulating T-Cell Repertoire Biomarkers of Response to Chemotherapy and Pd-1 Checkpoint Inhibitors in Patients With Stage IV Nsclc.. Journal of Clinical Oncology (2024)

Faisal YaseenRafael Santana-DavilaClemens GrassbergerDelphine L. ChenChristina BaikKeith D. EatonDiane TsengSmitha Patiyil MenonLei DengSylvia LeeAriana D JimenezPaul D. LampeA. McGarry HoughtonPaul E KinahanJing ZengStephen R. Bowen

stage iv nsclcpharmacologycancer immunotherapyfdg pet imagingimmunotherapyt-cell repertoire biomarkersoncologic imagingcancer researchradiation oncologymedicinal researchcellular therapytherapeutic imagingcancer caretumor targetinghematological malignanciescancer imagingmedicineexperimental medicinecancer immunosurveillanceclinical researchoncology

Long Term Outcomes in Patients With Recurrent/Metastatic (R/M) Salivary Gland Cancer (Sgc) Treated With Immune Checkpoint Inhibitors (Ici).. Journal of Clinical Oncology (2024)

Lauren ShihVicky WuKevin NgJenna M. VoutsinasAriana Dumenigo-JimenezJonathan R. FrommRenato G. MartinsKeith D. EatonRafael Santana-DavilaChristina S. BaikSylvia LeeDiane TsengLei DengBrittany BarberEmily MarchianoGeorge E. LaramoreJay Justin LiaoSimon S. LoUpendra ParvathaneniCristina P. Rodriguez

metastasisradiation oncologycancer immunotherapycancer researchpharmacologylong term outcomescancer managementclinical researchcancer treatmentsalivary gland cancercancer careoncology

Molecular Phenotyping of Small Cell Lung Cancer Using Targeted Cfdna Profiling of Transcriptional Regulatory Regions. Science Advances (2024)

Joseph B. HiattAnna-Lisa DoebleyHenry U. ArnoldMohamed AdilHolly SandborgThomas W. PersseMinjeong KoFeinan WuAlvaro Quintanal VillalongaRafael Santana-DavilaKeith EatonCaroline DiveCharles M. RudinAnish ThomasA. McGarry HoughtonGavin HaDavid MacPherson

molecular phenotypingthoracic oncologygeneticstumor biologycell biologygenomicslung cancercancer researchepigenomicsmolecular biologycfdna profilingmolecular cancermolecular diagnosticsscience advancecancer biologygenome biologytumor targetingtranscriptional regulatory regionscancer geneticscancer genomicsoncology

Abstract Ct116: First-In-Human Study of Azd8853, an Anti-Growth and Differentiation Factor 15 (Gdf15) Antibody, in Patients (Pts) With Advanced/Metastatic Solid Tumors. Cancer Research (2023)

Benedito A. CarneiroMaria DiabBrian A. Van TineAnthony F. ShieldsAlbiruni Abdul RazakJohn F. HiltonRafael Santana-DavilaElhan SanaiJorge Zeron-MedinaVeronique BragulatKath LoweryArthur LambertJohn HoodRakesh KumarDuncan JodrellPatricia LoRusso

anti-cancer agentsimmunologygenitourinary cancerspharmacologytumor biologycancer immunotherapycancer researchcancer cellsradiation oncologyfirst-in-human studymedicinal researchmolecular cancercellular therapycancer managementcancer carecancer biologymetastasistumor targetingclinical research

Dual Pd1 and Ctla4 Immune Checkpoint Blockade and Hypofractionated Radiation in Patients With Salivary Gland Cancers.. Journal of Clinical Oncology (2023)

Cristina P. RodriguezVicky WuKevin NgJenna M. VoutsinasAriana Dumenigo-JimenezJonathan R. FrommRenato G. MartinsKeith D. EatonRafael Santana-DavilaChristina S BaikSylvia LeeDiane TsengNeal D. FutranBrittany BarberEmily MarchianoJeffrey HoultonGeorge E. LaramoreJay Justin LiaoSimon S. LoUpendra Parvathaneni

clinical radiation oncologyradiation therapyradiation oncologycancer immunotherapyimmunologyimmunotherapysalivary gland cancerscancer researchimmune checkpoint inhibitorspharmacologycancer managementclinical researchpharmacotherapycancer treatmentcancer careoncology

1
2
3
4
5
10
10 / page

Rafael Santana-Davila, MD

Medical College of Wisconsin

Affiliations

Medical College of Wisconsin, Research

NoneRafael Santana-davila, Md is currently serving as a Medical College Of Wisconsin, Research faculty at Medical College of Wisconsin.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Rafael Santana-Davila, MD

Medical College of Wisconsin

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Dual Pd ‐1 and Ctla4 Immune Checkpoint Blockade and Hypofractionated Radiation in Patients With Advanced Salivary Gland Cancers. Head & Neck (2025)

Association of Napsin A-Specific T Cell Clonotypes With Durable Clinical Benefit to Immunotherapy in Patients With Metastatic Nsclc.. Journal of Clinical Oncology (2024)

Early Fdg Pet Imaging and Circulating T-Cell Repertoire Biomarkers of Response to Chemotherapy and Pd-1 Checkpoint Inhibitors in Patients With Stage IV Nsclc.. Journal of Clinical Oncology (2024)

Long Term Outcomes in Patients With Recurrent/Metastatic (R/M) Salivary Gland Cancer (Sgc) Treated With Immune Checkpoint Inhibitors (Ici).. Journal of Clinical Oncology (2024)

metastasisradiation oncologycancer immunotherapycancer researchpharmacologylong term outcomescancer managementclinical researchcancer treatmentsalivary gland cancercancer careoncology

Molecular Phenotyping of Small Cell Lung Cancer Using Targeted Cfdna Profiling of Transcriptional Regulatory Regions. Science Advances (2024)

Abstract Ct116: First-In-Human Study of Azd8853, an Anti-Growth and Differentiation Factor 15 (Gdf15) Antibody, in Patients (Pts) With Advanced/Metastatic Solid Tumors. Cancer Research (2023)

Dual Pd1 and Ctla4 Immune Checkpoint Blockade and Hypofractionated Radiation in Patients With Salivary Gland Cancers.. Journal of Clinical Oncology (2023)

1
2
3
4
5
10
10 / page

Similar Faculty Members

Trisha Wise-Draper, MD, PhD

Institution

University of Cincinnati

oral pathology

lung cancer

Scott Tagawa

Institution

Weill Cornell Medicine

oncology

urology

Rafael Santana-Davila

Institution

University of Washington

radiation oncology

thoracic oncology

Roger B. Cohen

Institution

University of Pennsylvania

oncology

radiation oncology

Balazs Halmos

Institution

Albert Einstein College of Medicine

receptor tyrosine kinase

anti-cancer agent

Hedy Kindler

Institution

University of Chicago

mesothelioma

pathology

David Nanus

Institution

Weill Cornell Medicine

oncology

urology

Nasser Altorki

Institution

Weill Cornell Medicine

oncology

lung cancer

Laura Esserman

Institution

University of California, San Francisco

systems integration

biomedical informatics

Jason J Luke

Institution

University of Pittsburgh

cancer letter

malignant disease

Similar Faculty Members

Trisha Wise-Draper, MD, PhD

Institution

University of Cincinnati

oral pathology

lung cancer

Scott Tagawa

Institution

Weill Cornell Medicine

oncology

urology

Rafael Santana-Davila

Institution

University of Washington

radiation oncology

thoracic oncology

Roger B. Cohen

Institution

University of Pennsylvania

oncology

radiation oncology

Balazs Halmos

Institution

Albert Einstein College of Medicine

receptor tyrosine kinase

anti-cancer agent

Hedy Kindler

Institution

University of Chicago

mesothelioma

pathology

David Nanus

Institution

Weill Cornell Medicine

oncology

urology

Nasser Altorki

Institution

Weill Cornell Medicine

oncology

lung cancer

Laura Esserman

Institution

University of California, San Francisco

systems integration

biomedical informatics

Jason J Luke

Institution

University of Pittsburgh

cancer letter

malignant disease